Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- artículu científicu (ast)
- bilimsel makale (tr)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- article scientifique (fr)
- 2003 nî lūn-bûn (nan)
- 2003年の論文 (ja)
- 2003년 논문 (ko)
- artículo científico publicado en 2003 (es)
- 2003年学术文章 (zh-cn)
- 2003年学术文章 (zh-sg)
- 2003年学术文章 (zh-hans)
- 2003年学术文章 (wuu)
- 2003年学术文章 (zh-my)
- 2003年學術文章 (zh-hk)
- 2003年學術文章 (zh-tw)
- 2003年學術文章 (zh-hant)
- 2003年學術文章 (yue)
- 2003年學術文章 (zh-mo)
- наукова стаття, опублікована в січні 2003 (uk)
- scientific article published in January 2003 (en)
- scientific article published in January 2003 (en-ca)
- scientific article published in January 2003 (en-gb)
- জানুয়ারি ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
- 2003年学术文章 (zh)
- مقالة علمية نشرت في يناير 2003 (ar)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Wood JM
- Newman RW
- Ploss K
|
rdfs:label
| - The use of correlates of immunity in European Union licensing of influenza vaccines. (en)
- The use of correlates of immunity in European Union licensing of influenza vaccines. (nl)
|
skos:prefLabel
| - The use of correlates of immunity in European Union licensing of influenza vaccines. (en)
- The use of correlates of immunity in European Union licensing of influenza vaccines. (nl)
|
name
| - The use of correlates of immunity in European Union licensing of influenza vaccines. (en)
- The use of correlates of immunity in European Union licensing of influenza vaccines. (nl)
|
title
| |
title
| - The use of correlates of immunity in European Union licensing of influenza vaccines (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
is about
of | |
is cites work
of | - Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy
- Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
- Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
- Reproducibility of serologic assays for influenza virus A (H5N1).
- Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study
- Quantitative review of antibody response to inactivated seasonal influenza vaccines
- Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant
- Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods
- Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trial
- Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers in South Apulia, Italy: a pilot study
- Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults
- Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
|
is cites work
of | |